Pasithea Therapeutics Corp. (KTTA): Price and Financial Metrics
KTTA Price/Volume Stats
| Current price | $2.58 | 52-week high | $9.40 |
| Prev. close | $2.66 | 52-week low | $2.37 |
| Day low | $2.50 | Volume | 8,923 |
| Day high | $2.66 | Avg. volume | 260,732 |
| 50-day MA | $3.31 | Dividend yield | N/A |
| 200-day MA | $5.21 | Market Cap | 3.27M |
KTTA Stock Price Chart Interactive Chart >
Pasithea Therapeutics Corp. (KTTA) Company Bio
Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. The company also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infusions of ketamine. Pasithea Therapeutics Corp. was incorporated in 2020 and is based in Miami Beach, Florida.
KTTA Price Returns
| 1-mo | -16.77% |
| 3-mo | -32.90% |
| 6-mo | -50.95% |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | -65.14% |
| 2023 | -42.34% |
| 2022 | -63.75% |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...